Stephen J Tapscott

USPTO Granted Patents = 9 (Patent Applications = 10)

EPO Patents = 4 (Patent Applications = 8)

Average Co-Inventor Count = 2.3

ph-index = 6

Forward Citations = 107(Granted Patents)

Company Filing History:

7 out of 289

Fred Hutchinson Cancer Center

patents

1 out of 8

Fred Hutchinson Cancer Research Center

patents

1 out of 975

University of Rochester

patents

4. 1 out of 15

Leiden University Medical Center

patents

5. 1 out of 271

Ionis Pharmaceuticals, Inc.

patents

6. 1 out of 219

Saint Louis University

patents

where one patent can have more than one assignee

Years Active: 1994-2025

Loading Chart...

9 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12458668 - Methods for treating facioscapulohumeral muscular dystrophy (2025-11-04),

2. 10865445 - Methods for alleviating facioscapulohumeral dystrophy (FSHD) by N siRNA molecule inhibiting the expression of DUX4-FL (2020-12-15),

3. 10538763 - Compounds and methods for modulation of DUX4 (2020-01-21),

4. 9814728 - Inhibition of DUX4 expression using bromodomain and extra-terminal domain protein inhibitors (BETi) (2017-11-14),

5. 8597880 - Methods and compositions for identifying increased risk of developing fragile X-associated disorders (2013-12-03),

6. 6444463 - Neurogenic differentiation gene neurod3 and methods for inducing differentiation of cells (2002-09-03),

7. 5795723 - Expression of neurogenic bHLH genes in primitive neuroectodermal tumors (1998-08-18),

8. 5695995 - Neurogenic differentiation (neurod) genes (1997-12-09),

9. 5352595 - Myod regulatory region (1994-10-04),

Title: The Inventor Spotlight: Stephen J Tapscott

Introduction: Stephen J Tapscott, a notable inventor based in Seattle, WA (US), has made significant contributions in the field of biomedical research and genetic therapies. With a total of 8 patents to his name, Tapscott is known for his innovative methods in alleviating Facioscapulohumeral Dystrophy (FSHD) through genetic modulation.

Latest Patents: Tapscott's recent patents focus on cutting-edge methods for alleviating FSHD by targeting the expression of the DUX4 gene. His inventions include techniques for screening human subjects to determine genetic predispositions to FSHD and developing compounds for modulating DUX4 gene expression. These patents showcase Tapscott's commitment to advancing treatments for genetic disorders.

Career Highlights: Tapscott has a rich professional background that includes working at renowned institutions such as the Fred Hutchinson Cancer Research Center and the University of Rochester. His expertise in molecular biology and genetic therapies has led to groundbreaking research in the field of neuromuscular diseases.

Collaborations: Throughout his career, Tapscott has collaborated with esteemed colleagues such as James M Olson and the late Harold M Weintraub. Together, they have pioneered innovative approaches to gene modulation and genetic therapies, leaving a lasting impact on the field of biotechnology.

Conclusion: Stephen J Tapscott stands out as a trailblazing inventor in the field of genetic therapies, particularly in the realm of alleviating FSHD. His dedication to research and development has paved the way for novel methods in genetic screening and modulation, offering hope for individuals affected by debilitating genetic disorders.

This text is generated by artificial intelligence and may not be accurate.